Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Was The Point-of-Care (POC) Coagulation Testing Devices Market Worth In 2025, And What Is Its Anticipated Value By 2029?
The market valuation for point-of-care coagulation testing instrumentation has experienced robust expansion recently, projected to advance from a figure of $2.12 billion in 2024 to $2.32 billion by 2025, reflecting a yearly compounded growth rate (CAGR) approximating 9.8%. This upward trajectory observed during the historical analysis period stems from several key factors, notably the rising incidence of both acute infectious conditions and long-term chronic illnesses, an expanding elderly demographic, greater adoption of compact, portable diagnostic tools, an increasing focus on biomarker analysis, and a heightened need for tailored medical treatments.
Anticipation points toward vigorous expansion within the market for point-of-care (poc) coagulation testing devices over ensuing years, projecting a valuation of $3.27 billion by 2029, propelled by an annual growth rate (CAGR) of 9.0%.This upward trajectory during the projection span is fundamentally driven by escalating needs for swift and precise disease identification, an increasing focus on health maintenance and prophylactic medical attention, the rising need for immediate, on-site diagnostic procedures, an uptick in outbreaks of contagious illnesses, and the increasing adoption of telemedicine services.Key developments set to shape this market in the forecast window involve the incorporation of next-generation sequencing (NGS), methodologies for RNA detection and evaluation, minute per-cell PCR examination techniques, the utilization of bioinformatics software alongside data interpretation aids, advancements in microfluidic systems, the deployment of lab-on-a-chip architectures, and the growing prevalence of point-of-care testing (POCT) integrated with artificial intelligence (AI) and sophisticated data analytical instruments.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15636&type=smp
What Are The Key Drivers Of Growth In The Point-of-Care (POC) Coagulation Testing Devices Market?
Anticipated expansion in the occurrence of conditions involving impaired blood coagulation is projected to fuel the market progression for point-of-care (POC) coagulation testing apparatuses; these disorders compromise the natural capacity of blood to form clots correctly, and lifestyle elements such as tobacco use, heavy drinking, and inactivity can exacerbate the situation by negatively influencing vascular integrity, levels of clotting agents, and circulation, thus heightening the likelihood of irregular clot development, while POC coagulation tools offer clinicians the capability to rapidly evaluate a patient’s clotting state, facilitating prompt alterations to prescribed therapies and regimens; specifically, data from the yearly worldwide census undertaken by the World Federation of Hemophilia, a Canadian international charity, indicated that in 2022, 427,685 persons were impacted by conditions causing bleeding, comprising 257,146 hemophilia sufferers, segmented further into 208,957 cases of Hemophilia A, 42,203 of Hemophilia B, and 5,986 identified as having an unspecified hemophilia type, alongside 70,034 individuals dealing with different bleeding ailments, underscoring how the increasing incidence of these coagulation issues acts as a catalyst for the point-of-care coagulation testing device sector’s growth.
What Are The Key Segments In The Point-of-Care (POC) Coagulation Testing Devices Market?
The point-of-care (poc) coagulation testing devicesmarket covered in this report is segmented –
1) By Product Type: Coagulation Monitors, Consumables, Coagulation Analyzers
2) By Technology: Optical Technology, Mechanical Technology, Electrochemical Technology
3) By Method: Prothrombin Time And International Normalized Ratio, Viscoelastic Coagulation Monitoring, Other Methods
4) By Application: Blood Glucose Testing, Infectious Diseases Testing, Cardiac Markers Testing, Coagulation Testing, Blood Gas And Electrolyte Testing, Other Applications
5) By End-User: Hospitals, Diagnostic Laboratories, Clinics, Other End-Users
Subsegments:
1) By Coagulation Monitors: Prothrombin Time (Pt) Monitors, International Normalized Ratio (Inr) Monitors, Activated Partial Thromboplastin Time (Aptt) Monitors, Whole Blood Coagulation Monitors, Clotting Time Monitors
2) By Consumables: Test Strips, Reagents, Control Solutions, Calibration Kits, Lancets And Needles
3) By Coagulation Analyzers: Portable Coagulation Analyzers, Benchtop Coagulation Analyzers, Fully Automated Coagulation Analyzers, Semi-Automated Coagulation Analyzers, Coagulation Testing Kits (For Home Use)
Which Trends Are Impacting The Point-of-Care (POC) Coagulation Testing Devices Market?
Leading firms within the point-of-care (POC) coagulation testing devices sector are concentrating efforts on creating immunofluorescence-based quantitative analyzers, aiming to enhance both the identification and handling of blood clotting ailments. These quantitative instruments employing immunofluorescence technology serve as analytical tools in clinical labs, specifically designed to gauge and ascertain the levels of particular substances pertinent to the coagulation cascade, thereby assisting in the diagnosis and oversight of conditions related to blood clotting. To illustrate, in the initial month of 2023, Cipla Limited, an enterprise situated in India that specializes in pharmaceuticals, introduced the Cippoint device. This particular analyzer, which relies on immunofluorescence methodology for quantitative measurement, is engineered to deliver precise test findings swiftly, usually within a window of three to fifteen minutes, thereby accelerating the time available for crucial clinical choices. Due to its intuitive design, rapid result delivery, and capacity to perform various tests, Cippoint plays a vital role in boosting diagnostic efficacy, supporting prompt medical determinations, and ultimately leading to better results for patients.
Who Are The Major Companies Operating In The Point-of-Care (POC) Coagulation Testing Devices Market?
Major companies operating in the point-of-care (POC) coagulation testing devices market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Medtronic plc, Siemens Healthineers, Koninklijke Philips N.V., Bio-Rad Laboratories Inc., Werfen, Haemonetics Corporation, Sonora Quest Laboratories, 23andMe Holding Co, Thorne HealthTech Inc., Metropolis Healthcare Limited, Color Health Inc., LetsGetChecked Inc., Ambry Genetics Corporation, MyHeritage Ltd., Genova Diagnostics Inc., Everlywell Inc., Complete Genomics Incorporated, DanteLabs Inc., HemoSonics LLC, Gene by Gene Ltd., Veritas Intercontinental, DirectLabs LLC, Full Genomes Corporation Inc., Ulta Lab Tests LLC, WellnessFX Inc., Any Lab Test Now Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Is Expected To Witness The Fastest Growth In The Point-of-Care (POC) Coagulation Testing Devices Market?
North America was the largest region in the point-of-care (POC) coagulation testing devices market in 2024. The regions covered in the point-of-care (POC) coagulation testing devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Point-of-Care (POC) Coagulation Testing Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=15636&type=smp
Browse Through More Reports Similar to the Global Point-of-Care (POC) Coagulation Testing Devices Market 2025, By The Business Research Company
Hospital Acquired Infections Testing Kits Global Market Report 2025
Pharma Microbiology Testing Kits Global Market Report 2025
Non Invasive Prenatal Testing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/non-invasive-prenatal-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model